The invention relates to a method for preventing or treating a disease or disorder that is associated with the MrgX2 receptor. The invention also relates to MrgX2 antagonists and physiologically acceptable salts thereof. The invention also relates to pharmaceutical compositions and dosage forms comprising an MrgX2 antagonist.
The Structure of Certain Polyazaindenes. II. The Product from Ethyl Acetoacetate and 3-Amino-1,2,4-triazole
作者:C. F. H. ALLEN、H. R. BEILFUSS、D. M. BURNESS、G. A. REYNOLDS、J. F. TINKER、J. A. VanALLAN
DOI:10.1021/jo01088a014
日期:1959.6
Synthesis of some new imidazo[1,2-<i>a</i>]pyrimidin-5(1<i>H</i>)-ones as potential antineoplastic agents
作者:El-Sayed Badawey、Thomas Kappe
DOI:10.1002/jhet.5570320355
日期:1995.5
Some substituted imidazo[1,2-a]pyrimidin-5(1H)-ones have been synthesized via the reaction of 2-aminoimidazole sulfate with some β-keto esters, diethyl ethoxymethylenemalonate and ethyl ethoxymethylenecyanoacetate. Several compounds were screened for their in vitro antineoplastic and anti-HIV activity but were inactive.
通过硫酸2-氨基咪唑与一些β-酮酯,乙氧基亚甲基丙二酸二乙酯和乙氧基亚甲基氰基乙酸乙酯的反应,合成了一些取代的咪唑并[1,2 - a ]嘧啶-5(1 H)- 。筛选了几种化合物的体外抗肿瘤和抗HIV活性,但没有活性。